Novo Nordisk NVO has outperformed the market over the past 10 years by 3.6% on an annualized basis producing an average annual return of 14.41%. Currently, Novo Nordisk has a market capitalization of $258.15 billion.
Buying $100 In NVO: If an investor had bought $100 of NVO stock 10 years ago, it would be worth $386.54 today based on a price of $114.03 for NVO at the time of writing.
Novo Nordisk’s Performance Over Last 10 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.